MyOme Launches Integrated Polygenic Risk Score for Prostate Cancer
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Prostate |
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Cerebrovascular |
The test measures two sugar alcohols to detect SORD-related neuropathy, which standard genetic tests sometimes miss.
Read MorePosted by CLP Edit Staff | Nov 19, 2025 | Company News |
The association’s incoming CEO brings more than two decades of leadership experience in global health, nonprofit management, and the scientific community.
Read MorePosted by CLP Edit Staff | Nov 18, 2025 | Sepsis |
The rapid diagnostic test achieved 100% sensitivity and negative predictive value in a 107-patient evaluation at Bordeaux University Hospital.
Read MorePosted by CLP Edit Staff | Nov 17, 2025 | Molecular Diagnostics |
Two studies show the advanced technique can identify chromosomal abnormalities missed by traditional genetic testing methods.
Read More